ArticleCancer epidemiology2025

Treatment switching between Enzalutamide and Abiraterone Acetate and time to oral opioid initiation in castration-resistant prostate cancer patients.

Ibrahim M Asiri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.